Graduate student Tushar Kamath takes an interdisciplinary approach to cancer research.

Gift will augment the Bridge Project, a collaborative project between the Dana-Farber/Harvard Cancer Center and MIT's Koch Institute.

Targeting the RNA-binding protein that promotes resistance could lead to better cancer therapies.

Protein-based sensor could detect viral infection or kill cancer cells.

Spinout’s microfluidics device better models how cancer and other cells interact in the body.

Researchers discover how the immune system can create cancerous DNA mutations when fighting off infection.

Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.

Researchers discover that aspartate is a limiter of cell proliferation.

Tweaks to the R&D pipeline could create new drugs and greater social benefit.

Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease.